Centaurus Financial’s Astera Labs ALAB Stock Holding History

Centaurus Financial’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523K	Buy	1,083 +167	+18%	+$44.3K	0.02%	570
2026 Q1	$100K	Buy	+916	New	+$130K	﹤0.01%	1044

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Centaurus Financial's ALAB Position: Q2 2026 in Review

Centaurus Financial increased its Astera Labs (ALAB) stake by 18% in Q2 2026, buying an estimated $44.3K and bringing the position to 1,083 shares worth $523K. The position accounts for 0.02% of the portfolio, ranked #570.

Centaurus Financial first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Centaurus Financial held 1,083 shares of Astera Labs worth $523K as of Q2 2026.
Centaurus Financial bought 167 Astera Labs shares in Q2 2026, an estimated $44.3K.
Astera Labs made up 0.02% of Centaurus Financial's portfolio in Q2 2026, its #570 holding.
Centaurus Financial first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.